Systemic lupus erythematosus (SLE)

The Challenge

A mid-sized global biopharmaceutical company sought to launch new therapies across various immunological indications, including systemic lupus erythematosus (SLE), in both the US and Europe. Given the novelty of these indications to the client team, they engaged with DKI Health. The goal was to swiftly comprehend pertinent global and regional policies, access landscapes, and crucial stakeholders, followed by the formulation and execution of strategic engagement plans.


Our Solution

  • Thoroughly assessed national and regional policies, health plans, as well as clinical and medical guidelines pertinent to systemic lupus erythematosus (SLE) and identified important priorities and gaps.

  • Conducted a comprehensive review of key government agencies, medical societies, advocacy organizations, payers, trade groups, and influential individuals (including KOLs, POLs, social media, and celebrity influencers) who have the potential to enhance comprehension and advance the treatment landscape for SLE.

  • Prioritized key stakeholders for client engagement according to a set of defined criteria, such as their ability to improve understanding and awareness of SLE, impact policy-shaping, and contribute to the betterment of diagnosis and treatment rates.

  • Developed a comprehensive stakeholder-specific engagement plan with key messaging and recommended activities.


Benefit to Client

  • Comprehensive Understanding of SLE Landscape: Acquired up-to-date insights into the dynamic external medical, policy, and access landscapes concerning systemic lupus erythematosus (SLE).

  • Stakeholder Engagement and Collaboration: Avenues for engagement and collaboration with pivotal external stakeholders, thereby ensuring an ongoing influence on the development of the disease landscapes.

  • Customized Messaging Materials: Tailored messaging documents, catering to the specific requirements of each stakeholder by region and country.

  • Strategic Stakeholder Engagement Plan: Formulated blueprint outlining recommended engagement approaches for each stakeholder.

Previous
Previous

Atopic Dermatitis